Navigation Links
Mindray Announces Second Quarter 2013 Financial Results
Date:8/5/2013

tal net revenues, compared to 8.7% in the second quarter of 2012 and 10.0% in the first quarter of 2013.

Research and development expenses for the second quarter of 2013 were $28.6 million, or 9.3% of total net revenues, compared to 8.9% in the second quarter of 2012 and 10.9% in the first quarter of 2013. Non-GAAP research and development expenses for the second quarter of 2013 were $27.4 million, or 8.9% of total net revenues, compared to 8.4% in the second quarter of 2012 and 10.5% in the first quarter of 2013.

Total share-based compensation expenses, which were allocated to cost of revenues and related operating expenses, were $3.2 million in the second quarter of 2013 compared to $6.0 million in the second quarter of 2012 and $4.8 million in the first quarter of 2013.

Operating income was $66.7 million in the second quarter of 2013, a 19.4% increase from $55.9 million in the second quarter of 2012. Non-GAAP operating income in the second quarter of 2013 was $73.1 million, a 15.2% increase from $63.5 million in the second quarter of 2012. Operating margin was 21.7% in the second quarter of 2013 compared to 20.9% in the second quarter of 2012 and 16.1% in the first quarter of 2013. Non-GAAP operating margin was 23.8% in the second quarter of 2013 compared to 23.7% in the second quarter of 2012 and 19.1% in the first quarter of 2013.

Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA")Second quarter 2013 EBITDA increased 18.8% year-over-year to $78.9 million from $66.4 million in the second quarter of 2012.

Net IncomeNet income increased 19.3% year-over-year to $62.1 million from $52.0 million in the second quarter of 2012. Non-GAAP net income increased 14.7% year-over-year to $68.2 million from $59.5 million in the second quarter of 2012. Net margin was 20.2% in the second quarter of 2013 compared to 19.4% in the second quarter of 2012 and 23.7% in the first quarter of 2013. Non-GAAP net margin was 22.2
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
2. Mindray Medical to Acquire Controlling Stake in Hangzhou Optcla Medical Instrument
3. Mindray Announces First Quarter 2012 Financial Results
4. Mindray Medical to Present at AACC Clinical Lab Expo 2012
5. Mindray Medical Completes Acquisition of Dragonbios Orthopedics Business
6. Mindray to Report Second Quarter 2012 Financial Results on August 6, 2012
7. Mindray Announces Second Quarter 2012 Financial Results
8. Mindray Medical to Participate in MEDICA 2012 in Dusseldorf, Germany
9. Mindray Medical Announces Top Management Change
10. Mindray DS USA, Inc. has Initiated a Voluntary Recall Affecting the A3/A5 Anesthesia Delivery System
11. Mindray to Showcase Enhancements to DC-8 Ultrasound System at RSNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... PITTSBURGH , June 3, 2015 Mylan ... today announced that the Company will present at Goldman Sachs ... 9, 2015. The presentation is scheduled to begin at 4 ... parties can access a live webcast of the presentation via ... .   Mylan is a global pharmaceutical company ...
(Date:6/3/2015)... , June 3, 2015  NxStage Medical, Inc. (Nasdaq: ... dialysis products , today announced data that home ... 221 million gallons of water annually by transitioning ... to home hemodialysis with the NxStage® System One™.  ... 429 gallons of water per patient per week, ...
(Date:6/3/2015)... SEATTLE , June 3, 2015 ... acquire Northeast Pharmaceuticals, Inc., bringing together two pharmacy organizations ... with mental illness. Both companies have strong reputations for ... their customers. Genoa ... the behavioral health community and those affiliated with managing ...
Breaking Medicine Technology:Home Hemodialysis With NxStage System One Can Save California 221 Million Gallons of Water Annually 2Genoa, a QoL Healthcare Company Acquires Northeast Pharmaceuticals, Inc. 2
... announced Phase 2b trial results for its investigational compound ... 30 to 40 percent in patients whose TG levels ... included an arm combining DCCR with fenofibrate treatment (Abbott ... was shown to be additive to fenofibrate for all ...
... HILL, N.C., Feb. 29, 2012  Cempra, Inc. (NASDAQ: ... Fernandes, Ph.D., president and chief executive officer, will present ... Conference at 11:20 a.m. EST, March 6, 2012, at ... will provide an overview of the company,s two leading ...
Cached Medicine Technology:Phase 2b Trial Shows Unique Lipid Efficacy Profile of Novel Compound to Reduce Elevated Triglyceride Levels 2Phase 2b Trial Shows Unique Lipid Efficacy Profile of Novel Compound to Reduce Elevated Triglyceride Levels 3Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference 2
(Date:6/3/2015)... California (PRWEB) June 03, 2015 ... biopharmaceuticals or biologics has revolutionized disease treatment on account ... cancer and autoimmune diseases, such as rheumatoid arthritis. The ... the use of traditional small molecule drugs to biopharmaceuticals ... monoclonal antibodies (mAbs), cell and gene therapies, and recombinant ...
(Date:6/3/2015)... NY (PRWEB) June 03, 2015 Dr. Steven ... York Cardiac Diagnostic Center ( http://www.newyorkcardiac.com ) located in NYC, ... on weekdays to his practice. In most cases, depending on ... of the day they call, they will be seen by ... first priority as a cardiologist is to ensure that people ...
(Date:6/3/2015)... New York, NY (PRWEB) June 03, 2015 ... new strategic partnership to expand online and mobile ... including Board Review and Maintenance of Certification (MOC) ... Decker will market VeoMed’s innovative courses to Decker’s ... healthcare professionals interested in purchasing access to VeoMed’s ...
(Date:6/3/2015)... Z-Medica®, LLC, a leading developer and marketer ... designated as National Safety Month by the National Safety ... for its commitment to public safety. , The ... Aid Kits (IFAK) over 100 times in the past ... traffic accidents. Each kit is equipped with what’s needed ...
(Date:6/3/2015)... For the fourth time in less than ... full-service advertising agency, has been honored by a respected independent ... MCA has been selected as a Semi-Finalist for the 2015 ... honored at a luncheon sponsored by Adcock Financial Group and ... Art. , “This luncheon will include important information about the ...
Breaking Medicine News(10 mins):Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 2Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 3
... Iraq, Afghanistan who sought medical care were victims , , ... the challenges facing women in the military, a new ... Iraq and Afghanistan veterans seeking VA medical care reported ... reported sexual trauma, such as rape and threatening sexual ...
... ), a leading provider of Manufacturing Process Intelligence software, announced ... and chief science officer, and Joe Rothman, Aegis’ vice president ... life sciences industry events in Germany and Spain. ... ...
... lung cancer called video-assisted thoracic surgery or VATS is ... centers. Now, a preliminary study to be presented ... is giving surgeons an early look at its benefits. ... a six to 10-inch incision, cutting the major muscles ...
... , Montreal, October 28, 2008 - Patients 80 years ... able to withstand open-heart surgery, according to the latest study ... (MUHC). His findings were presented this morning in Toronto during ... a reason for doctors to rule out the possibility of ...
... Compression Fracture Treatment Using Ultra-High Viscosity ... Oct. 28 DFine, Inc., a developer of,minimally ... secured a $30 million round of investment in ... and Highland Capital Management. Other investors,include Prospect Venture ...
... research study just published in,a major national journal reports ... over the last six years. But experts at U.S.,Preventive ... costs are far higher and that more can be ... people healthy., (Logo: http://www.newscom.com/cgi-bin/prnh/20080506/NETU129LOGO ), ...
Cached Medicine News:Health News:Sexual Trauma Haunts Many Female Vets 2Health News:Sexual Trauma Haunts Many Female Vets 3Health News: Aegis to Present on Global Stages : Company to Discuss How Manufacturing Process IntelligenceSupports Tech Transfer and Product Lifecycle Management 2Health News: Aegis to Present on Global Stages : Company to Discuss How Manufacturing Process IntelligenceSupports Tech Transfer and Product Lifecycle Management 3Health News:Highly specialized, minimally invasive surgery for lung cancer allows patient to go home sooner 2Health News:DFine Secures $30 Million in Series D Funding 2Health News:U.S. Preventive Medicine Says Prevention Can Keep Diabetes Costs From Rising 2
... peripheral nerve stimulator automatically ... nerve locator or a ... upon which patient lead ... NSL-5 electrode lead set, ...
Low pressure automatic tourniquet with manual time. Includes extension hose and spiral replacement hose....
... Universal Hand Holder and Retractor Set ... hand in any position needed. Ball ... or tendon hooks, fixate the hand ... the patient's hand held firmly, the ...
Stryker Instruments, the leader in cordless power, advances orthopaedics with the power, speed, versatility, reliability and performance through its heavy duty powered instruments....
Medicine Products: